Home » Newsletters » BioWorld Science

BioWorld Science

April 13, 2005

View Archived Issues

Levetiracetam improves chorea symptoms in patients with Huntington's disease

Ralfinamide induces analgesic effects in patients with neuropathic pain

VasoGenix and QLT to develop new treatment for congestive heart failure

CT-011 completes phase I study in advanced hematological malignancies

Intercell and Biological E sign Asia agreement for Japanese encephalitis vaccine

FDA clears phase I study of systemic administered Reolysin

AustCancer submits DMF for GPI-0100

Innovate Oncology acquires rights to Capridine-Beta for prostate cancer

BAL-5788 enters hospital-acquired pneumonia phase III trials

Fosamax Plus D receives FDA approval

Celgene completes Revlimid NDA submission for MDS

Eisai and Abbott to develop adalimumab for psoriasis in Japan

Bausch & Lomb discloses new therapeutic agents for ophthalmic diseases

Retisert receives FDA approval

New patents cover treatments for pain and inflammation

New data on the antiviral efficacy and the PK of celgosivir

Long-term effects of transdermal rotigotine in patients with early PD

A new study confirms the benefits of eszopiclone in chronic insomnia

Lasofoxifene induces no adverse effects on mood and cognition in postmenopausal women

Japanese manufacturing approval for tocilizumab for Castleman's disease

Japanese manufacturing approval for Lulicon

Promising results from in vitro and in vivo testing of human rhinovirus inhibitor

Prana will not advance PBT-1 into PLACQUE study

Long-acting naltrexone reduces heavy drinking in alcohol-dependent subjects

Phase III results on lucinactant in premature infants at risk for RDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...